good in I5, four were fair only and five were poor.
Not many years ago little interest was taken in the articular diseases. The field of ' rheumatism ' was a loosely defined one and in this ill-defined area physician, orthopaedic surgeon, physiotherapist and others wandered rather at random. Therapy was and still is largely palliative and empirical. The rheumatoid in particular derived little help from any form of therapy except certain forms of physiotherapy, splinting, support and graded rest, measures which are still the backbone of treatment. Knowledge of the exact aetiological agents, without which therapy must continue to be empirical, is still lacking. Since the war more attention has been devoted to the study of this group of disorders and, when in 1949 Hench and his colleagues reported the dramatic effect of cortisone on rheumatoid arthritis, a great impetus was given to research into study of diseases of the locomotor system. Now, three years later, it is perhaps time to take stock of the present position.
Nomenclature
A glance at the history of medicine shows certain concertina-like features in the study of disease groups in which the aetiology is unknown. 'A,' a great man in his day, classifies all the diseases and points out their differences, splitting them into sub-groups on clinical and pathological grounds. 'B,' equally eminent, some years later draws attention to points of similarity throughout the whole group and unifies them as best he can. Later ' C,' a brilliant young worker, splits them up again and adds his name to two syndromes which emerge from the reshuffle. In the absence of exact knowledge this can go on indefinitely. A prolonged search for infective agents has, except in a few instances, proved fruitless in the field of rheumatology and there seems little to hope for in this direction with current methods. The pendulum is now over to host reaction rather than invading organism, to disease of soil rather than seed. The recent paper of Kellgren (1952) should be read in this context.
In this country our classification of the rheumatic disorders is in agreement with that used in the United States of America with only few exceptions. Only the more cornmon disorders are discussed below.
POSTGRADUATE MEDICAL JOURNAL Rheumatoid Arthritis
This disorder is the most serious of those to be considered. While not as common as degenerative (osteo) arthritis it remains a great scourge and a major cause of loss of working time.' It may affect anyone of either sex from three years of age onwards. While commonest' in the female sex in middle age it is no respecter of persons and may occur out of the blue in a previously normal person of any age, even in the eighties. There is no evidence that physical or psychological trauma or any specific infection brings it on in most cases; in the vast majority no such factors can be found and the careful controlled study by the Empire Rheumatism Council (1950) Although such cell foci have been reported in normals and in other diseases they seem vastly more common in rheumatoid arthritis than any other disease process and are almost always negative in gout, ankylosing spondylitis and osteoarthritis (Freund, 1945; Desmarais et al., 1948) .
Although cardiac lesions are reported (Rosenberg, 1949) in rheumatoid arthritis they are essentially rarities of histological interest for there is little clinical evidence of rheumatoid disease of the heart in life. The same applies to rheumatoid disease of the lung though some possible cases are reported (Ellman, 1948; Hart, 1948) .
Rheumatoid arthritis, as has been pointed out by many workers, is not just a disease of bones, joints and cartilage, but is characterized by generalized systemic upset with changes in muscles, tendons and other tissues. The alternative title, rheumatoid disease, has much to commend it.
As regards therapy, graded rest and graded exercises and exercise, with supportive measures and immobilization of the acutely inflamed joint remain, with general heajlth measures, the backbone of treatment. Analgesics are essential for most cases and acetyl salicylic acid (aspirin) in one form or another, remains the most popular and the most widely taken. Cortisone (Compound E) and corticotropin (ACTH) are the most effective anti-inflammatory agents to date, for they not only reduce pain but also swelling and stiffness. In mild cases they may remove all signs of the disease in therapeutic doses; in more severe cases only partial suppression can be achieved in doses that will not cause undesirable side-effects. There is no doubt that these drugs will temporarily -reverse, in part at least, the disease process, but the effect in most cases is only partial and in all cases is temporary. Even after a year's continuous therapy, relapse will occur within a few days or weeks of stopping treatment. As cortisone is given by mouth it is the drug of choice in rheumatoid arthritis, as corticotropin (ACTH) has to be given by injection. At present the majority of rheumatologists prefer to give the smallest maintenance dose that will maintain the patient approximately 70 per cent. free from symptoms and signs; total suppression is not now the aim. There is no doubt that effective temporary suppression can be achieved in the majority of moderate cases in such dosage and few people pow use more than 75 mgm. a day, dosage being by mouth three to four times a day evenly spaced before meals. Continued dosage higher than this may prove dangerous and should not be used. More heavy dosage, in the region of 500 mgm. a day (Bayles, I952) , in the hope of giving more prolonged remission, has been tried, found unsatisfactory and has been given up. Most patients, then, can be promised partial temporary freedom from symptoms and signs. They cannot be promised a cure or even a lasting remission. There is no evidence that this treatment halts the disease or makes a natural remission more likely. There is no evidence either way to date that it speeds up or slows down radiological changes. The treatment carries certain risks that should constantly be kept in mind:
(i) Mild side effects are of little import and are usually controlled by slight dose reduction. They include the round moon face, acne and striae on abdomen and shoulders. Electrolyte disturbances are usually slight and temporary; as there is in some cases sodium retention and/or increased potassium loss in the urine some physicians prefer to restrict salt intake while on therapy and to give potassium supplements (2 to 4 gm. potassium chloride a day by mouth).
(2) Osteoporosis may occur. While in the average case this complication remains a remote risk only, in patients already suffering from postmenopausal or old-age osteoporosis this therapy may readily lead to crush fractures of the thoracic or lumbar vertebrae. The bedridden or only slightly active patient who cannot on treatment be adequately mobilized runs a very real risk of this complication and the drug is best given only to patients who can be adequately and reasonably rapidly mobilized on therapy.
(3) Patients with irreversible bony change as the cause of their crippling will improve little and there will be no improvement on therapy in old fixed disease. Cortisone or corticotropin treatment in such cases can be used as a short-term measure to facilitate the instigation of other forms of treatment, but should not be continued as long-term therapy unless reasonably full mobilization can be achieved.
(4) There is a real risk of gastric or duodenal ulceration. Haemorrhage as 25 mgm. per diem it is likely that the disease has spontaneously settled under cover of the drug, which may then be discontinued for a trial period, permanently if there is no relapse. When treatment is discontinued it is best gradually to taper off the dosage; sudden cessation at high therapeutic level leads to the so-called rebound phenomenon, the disease returning with a rush to a state even worse than before treatment, usually with great mental upset and distress and occasionally with signs of partial adrenal insufficiency.
Short-term therapy, to cover short extremely painful bouts of activity and to precede and follow surgical or manipulative measures is entirely reasonable. Cortisone, though it can be given by one intramuscular injection a day, is now almost invariably administered by mouth at regular sixto eight-hourly intervals before meals.
Little has been said so far of corticotropin -(ACTH). It is less useful in rheumatoid arthritis 'as it cannot be given orally, but intramuscularly six-or eight-hourly in doses varying from 20 to 8o mgm. a day it may be used for short-term therapy. The hazards are as with-cortisone, but as it is rarely used for long-term therapy the complications of long-term suppressive treatment hardly arise. Abscesses. and bruising occasionally give trouble at the site of injection. It may also be given intravenously and it appears that 20 mgm. given continuously intravenously over a period of eight hours gives approximately the adrenal cortical stimulation afforded by 8o to I00 mgm. or more intramuscularly by divided dosage. It has also been given subcutaneously with the spreading factor hyaluronidase. Here there is a risk of spreading infection unless aseptic technique is flawless.
Finally, hydrocortisone (Compound F) unlike cortisone (Compound E) has proved of value in local treatment and instillation into joints has given good results in the hands of Hollander (1952) and others. The effect appears to be entirely suppressive and not curative. Dosage depends on the size of the joint: 25 mgm. for a knee, I to 2 mgm. for a finger joint. Doses of more than 50 mgm, even for a large joint, are not recommended and even at this dosage they may cause local exacerbation of swelling and pain. Such injections may be given as often as required, usually every one to three weeks, until the affected joint subsides, the dosage being then spaced out with longer intervals between.
Hydrocortisone may be used locally in conjunction with general oral cortisone treatment.
Although a useful addition to therapy, it remains palliative and needs to be repeated frequently. The patient must be warned not to over-exercise the joint when relief is obtained. The drug should be given with strict aseptic technique or there is risk of infection, but this can be done in consulting room or surgery and without resort to full operating theatre conditions. It has at the time of writing received only scanty trial in the United Kingdom.
A host of other substances have been tried; with the exception of cortisone, hydrocortisone and corticotropin all have been found wanting. Pregnenolone, deoxycortone and ascorbic acid and many others have now been generally discarded. ' Irgapyrin ' (Geigy) has the disadvantage of containing amidopyrine which, because of the risk of causing agranulocytosis, has long been viewed with disfavour both in the United Kingdom and the U.S.A. Its solvent, butazolidine, orally or by injection, has good analgesic properties but probably no true anti-rheumatic ones. In my own series of cases no constant effect was noted in in reduction of swelling, though pain relief did occur in most cases. Currie (195i) , however, who made the original observation that butazolidine was as effective as ' Irgapyrin,' finds reduction of swelling in about one-third of his patients.
Finally, one of the most vital and often the most difficult thing to decide in rheumatoid arthritis is what measure of local and general exercise to allow. Uncontrolled rest is worse than no rest at all; an untreated patient who has kept active is perhaps crippled but is getting about, while the untreated one who has given up the struggle and taken to bed and chair has almost certainly developed deformities which may prevent her walking again. Every case in this respect is an individual problem; whatever programme is started in hospital the physician must see to it that this is continued religiously at home. All too often relapse occurs soon after returning home either because the patient has broken the rules or because the therapeutic prograumme was insufficiently detailed by the physician.
Ankylosing Spondylitis (Rheumatoid Spondylitis)
This disorder is considered in the United Kingdom to be sufficiently distinct, clinically, radiologically and therapeutically, to be considered as a separate disease entity, though in the U.S.A. the latter title is used as it is considered to be a variant of rheumatoid arthritis. As the aetiology of neither of these conditions is known, it seems to me to be reasonable to keep it as a separate entity until such time as more is known of the aetiology of the rheumatic diseases as a whole. Clinically it is different in that the patient is usually a young male, and the disease largely-if not entirely-confined to spine, pelvis and thorax, peripheral involvement being more rare, with finger and wrist involvement rarer still.
Radiologically, the sacro-iliac joints, almost invariably normal in rheumatoid arthritis, are invariably abnormal in ankylosing spondylitis. Therapeutically deep X-ray therapy, of little or no help in the treatment of rheumatoid arthritis, is the therapy of choice in ankylosing spondylitis, together with suitable spinal and breathing exercises and measures designed to avoid kyphotic deformity. As immobilization tends to increase and accelerate stiffness and fusion, much more activity is allowed the spondylitic than the rheumatoid and unless the disease is in acute exacerbation he is not confined to bed. Deep X-ray therapy is now administered locally to the spine and sacro-iliac joints; the wide-field' X-ray bath' of Gilbert Scott is no longer given. While not curative, prolonged remissions frequently occur lasting several months or in some cases years. Almost all patients experience symptomatic improvement. Cortisone and corticotropin are of great help in the acute phases; relapse tends to occur as soon as therapy is discontinued unless natural remission has set in (Hart, 1952) . Few spondylitics are so bad that continuous therapy need be considered, though such cases do occur. Plaster shells and prolonged immobilization in any form are now considered an incorrect form of therapy; light supporting jackets to maintain good position are advocated by some (Swaim, 1939) , though others consider the benefit slight or non-existent. Certainly most jackets I have seen on patients have been too heavy and cumbersome and have restricted full respiratory movements without controlling posture adequately. As the thorax is involved in this disease, costovertebral and costo-transverse joints being affected so that rib movements are restricted and vital capacity reduced by reduction of supplemental and complemental air, breathing exercises are usually advocated as a routine measure; supports that restrict respiration are therefore contraindicated. This does not apply to the light supporting jacket advocated by Swaim, which does not restrict thoracic expansion and is constructed to throW the spine into slight extension on full inspiration. For marked forward curvature of the spine, wedge osteotomy may be performed (Smith-Petersen, 1945; Law, I949) , the upper portion of the spine above the bone wedge removed heing 'rocked back' on the lower. (5) Local injections of procaine or, more recently, hydrocortisone. Unfortunately the hip is the most difficult of joints to inject and one of the commonest to be involved.
(6) Surgery-arthrodesis, cup arthroplasty or, more popular at the moment, an acrylic prosthesis, the diseased femoral head being replaced by an acrylic cup and stem. Vitallium and stainless steel is also used. Kellgren and Moore (1952) have pointed out that oseto-arthritis can come on acutely and painfully and in its generalized form is not infrequently mistaken for rheumatoid arthritis. Heberden's nodes may, in the early stage be hot, painful and throbbing; only later on are they the classical painless bony nodularities. In most cases, however, the two diseases are sufficiently distinct to allow of accurate firm diagnosis.
Conclusions
It is impossible to summarize a summary. The most interesting event since the war in the field of rheumatism has been the discovery of the effects of some of the adreno-cortical hormones on rheumatoid disease. This has intensified and concentrated research in a previously rather neglected field of medicine. Rheumatism is responsible for more suffering and more loss of working time than any other organic disease; because it holds no immediate risk to life it has not the dramatic appeal of other disorders to therapist, research worker or generous donor. Nevertheless, it is of prime importance to the community to attack this group of diseases with all methods available. This country has in the past made many major therapeutic discoveries; let us hope its next will be in the field of rheumatic disease. There is no shortage of clinical material.
